Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Fujimura

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Optics Letters|July 2, 2016
Dual-frequency injection-locked continuous-wave near-infrared laserTrivikramarao Gavara, Takeru Ohashi, Yusuke Sasaki, et al.
Endocrine Journal|May 29, 2018
Efficacy and safety of sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION)Takashi Nomiyama, Dai Shimono, Tsuyoshi Horikawa, et al.
Plos One|August 11, 2017
Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patientsYuki Fujimura, Yohei Yamauchi, Takayo Murase, et al.
Diabetology International|August 18, 2020
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)Yuichi Terawaki, Chikayo Iwaya, Takashi Nomiyama, et al.
Endocrine Journal|November 29, 2019
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferationShiho Komatsu, Takashi Nomiyama, Tomohiro Numata, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2018
Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's SyndromeIchiro Abe, Kaoru Sugimoto, Tetsumasa Miyajima, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Optics Letters|July 2, 2016
Dual-frequency injection-locked continuous-wave near-infrared laserTrivikramarao Gavara, Takeru Ohashi, Yusuke Sasaki, et al.
Endocrine Journal|May 29, 2018
Efficacy and safety of sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION)Takashi Nomiyama, Dai Shimono, Tsuyoshi Horikawa, et al.
Plos One|August 11, 2017
Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patientsYuki Fujimura, Yohei Yamauchi, Takayo Murase, et al.
Diabetology International|August 18, 2020
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)Yuichi Terawaki, Chikayo Iwaya, Takashi Nomiyama, et al.
Endocrine Journal|November 29, 2019
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferationShiho Komatsu, Takashi Nomiyama, Tomohiro Numata, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2018
Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's SyndromeIchiro Abe, Kaoru Sugimoto, Tetsumasa Miyajima, et al.
Pageof 2